| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34d84d92eec9f232ace0dcb0df59c22c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_266b42954d9172f5087c536afede1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7349ea237e4e4d66531f15303061a081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6cb677da2eaec4cd8d3fbbcbb816ee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ebfbc09c17e4366b18b3669a037cd14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dd75042cc7d92ba35b2021270b484dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7808ce6471be5db8d3dbdbb89076e52 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_303ef4d3bb5865b9b014c2503aa89a80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6491d7a54eed1e76bbbe3e8ff676b821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b9999b0b240b616b4d1f15c4c76644a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_416ccad1ec4e8e0f154ee8064bbfdcd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd99e0020a74455f3fca24b051213fbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72326b74193bc560c1d46b34a6ca63a3 |
| publicationDate |
2013-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013317201-A1 |
| titleOfInvention |
Anti-cdh3 antibody having high internalization capacity |
| abstract |
It is an object of the present invention to provide an anti-cadherin antibody having a high internalization capacity and provide an anti-cadherin antibody-drug conjugate that effectively kills cadherin-expressing cancer cells with the use of such antibody. The present invention provides an anti-cadherin antibody which recognizes a cadherin domain 1 (EC1) of cadherin and exhibits a high internalization capacity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11352440-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10087258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10005836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10653791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013058947-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9534058-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9884921-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10626172-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9605080-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10167343-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9644028-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10100129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10214584-B2 |
| priorityDate |
2010-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |